Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Germany

Research and Innovation Action · Running

Psych-STRATA Psych-STRATA - A Stratified Treatment Algorithm in Psychiatry: A program on stratified pharmacogenomics in severe mental illness

Coordinator
Universitaet Muenster, Germany
Runs
1 October 2022 to 30 September 2027
Status
Running
EU funding
€10.3m
Total cost
€10.3m
Partners
31 organisations in 14 countries
Type
Research and Innovation Action
Grant agreement
101057454

What the project is doing

In the project's own words, from its summary on CORDIS.

A key problem in Mental Health is that up to one third of patients suffering from major mental disorders develop resistance against drug therapy. However, patients showing early signs of treatment resistance (TR) do not receive adequate early intensive pharmacological treatment but instead they undergo a stepwise trial-and-error treatment approach. This situation originates from three major knowledge and translation gaps: i.) we lack effective methods to identify individuals at risk for TR early in the disease process, ii.) we lack effective, personalized treatment strategies grounded in insights into the biological basis of TR, and iii.) we lack efficient processes to translate scientific insights about TR into clinical practice, primary care and treatment guidelines.

It is the central goal of PSYCH-STRATA to bridge these gaps and pave the way for a shift towards a treatment decision-making process tailored for the individual at risk for TR. To that end, we aim to establish evidence-based criteria to make decisions of early intense treatment in individuals at risk for TR across the major psychiatric disorders of schizophrenia, bipolar disorder and major depression. PSYCH-STRATA will i.) dissect the biological basis of TR and establish criteria to enable early detection of individuals at risk for TR based on the integrated analysis of an unprecedented collection of genetic, biological, digital mental health, and clinical data. ii.) Moreover, we will determine effective treatment strategies of individuals at risk for TR early in the treatment process, based on pan-European clinical trials in SCZ, BD and MDD.

These efforts will enable the establishment of novel multimodal machine learning models to predict TR risk and treatment response. Lastly, iii.) we will enable the translation of these findings into clinical practice by prototyping the integration of personalized treatment decision support and patient-oriented decision-making mental health boards.

Topics

Who is involved

OrganisationCityCountryRole
Universitaet MuensterMuensterGermanyCoordinator
The University of AdelaideAdelaideAustraliaAssociatedpartner
Global Alliance of Mental Illness Advocacy Networks Europe AisblBruxelles / BrusselBelgiumParticipant
Katholieke Universiteit LeuvenLeuvenBelgiumParticipant
World Psychiatric AssociationThonexSwitzerlandAssociatedpartner
Novamechanics LimitedNicosiaCyprusThird party
Charite - Universitaetsmedizin BerlinBerlinGermanyParticipant
European Research Services GmbHMunsterGermanyParticipant
Fraunhofer Gesellschaft Zur Forderung Der Angewandten Forschung eVMunchenGermanyParticipant
Kairos GmbHBochumGermanyParticipant
Karlsruher Institut Fuer TechnologieKarlsruheGermanyParticipant
Klinikum Der Ludwig-Maximilians-Universitat MunchenMunchenGermanyThird party
Ludwig-Maximilians-Universitaet MuenchenPlaneggGermanyParticipant
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften eVMunchenGermanyParticipant
Region HovedstadenHillerodDenmarkParticipant
Novamechanics Monoprosopi IkePiraeusGreeceParticipant
Fundacio Centre De Regulacio GenomicaBarcelonaSpainParticipant
Fundacio De Recerca Clinic Barcelona-Institut D Investigacions Biomediques August Pi I SunyerBarcelonaSpainParticipant
Fundacion Para La Investigacion Biomedica Del Hospital Gregorio MaranonMadridSpainParticipant
Hospital Clinic De BarcelonaBarcelonaSpainThird party
Institut Du Cerveau Et De La Moelle EpiniereParisFranceParticipant
Alma Mater Studiorum - Universita Di BolognaBolognaItalyParticipant
Associazione Oasi Maria SS. OnlusTroinaItalyParticipant
Universita Degli Studi Di BresciaBresciaItalyParticipant
Universita Degli Studi Di CagliariCagliariItalyParticipant
Universitair Medisch Centrum UtrechtUtrechtNetherlandsParticipant
Oslo Universitetssykehus HfOsloNorwayParticipant
Universitetet I OsloOsloNorwayThird party
Goeteborgs UniversitetGoeteborgSwedenParticipant
Cardiff UniversityCardiffUnited KingdomAssociatedpartner
King's College LondonLondonUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI